Unraveling the Mechanism: Scientists Pinpoint the Crucial Role of the Fc Fragment in Lecanemab’s Alzheimer’s Plaque Clearance
A groundbreaking study by scientists at VIB and KU Leuven has definitively illuminated the precise mechanism by which lecanemab, the monoclonal antibody treatment marketed as Leqembi, combats Alzheimer’s disease. This…
Unlocking Alzheimer’s Plaque Clearance: VIB and KU Leuven Scientists Reveal Crucial Role of Antibody’s Fc Fragment in Microglial Activation
A groundbreaking study by scientists at the VIB and KU Leuven has precisely delineated the mechanism by which lecanemab, marketed as Leqembi, a monoclonal antibody treatment for Alzheimer’s disease, effectively…








